Parkmore Business Park West
About Vivasure MedicalVivasure Medicalhas developed and patented a bioabsorbable implant platform technology for applications in vessel closure. Its first product from this platform features a fully absorbable implant and percutaneous delivery system, designed to close large (up to 24F) arteriotomies. The first product is in the clinical phase of development, where it is being used to close large arteriotomies in the common femoral artery. The company plans to expand its platform technology to meet the growing market demand for absorbable, percutaneous vessel closure products.
Founder and CEO: Gerard Brett
Founder and CTO: Christopher Martin
CMO: Paul Teirstein
3 articles with Vivasure Medical
Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the European launch of the PerQseal® closure device for large-bore transcatheter procedures.